A

Arkansas Children's | Arkansas Children's Hospital - Arkansas Children's Research Institute - Neurology Department

Research site
(Unclaimed)
Location
1 Children's Way Slot 846, Little Rock, Arkansas, United States of America
Site insights

Top conditions

Muscular Dystrophies (2 trials)

Migraine Disorders (2 trials)

Duchenne Muscular Dystrophy (1 trial)

Sarcoglycanopathies (1 trial)

Limb-Girdle Muscular Dystrophies (1 trial)

Top treatments

LY573144
Lasmiditan

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of m...

Enrolling
Migraine
Drug: Lasmiditan

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks an...

Enrolling
Migraine
Drug: Placebo
Drug: Lasmiditan

The study will evaluate the safety and efficacy of gene therapy in boys with DMD. It is a randomized, double-blind, placebo-controlled study with two...

Active, not recruiting
Duchenne Muscular Dystrophy
Genetic: PF-06939926
Other: Placebo

Trial sponsors

Lilly logo

Lilly (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems